Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for intragastric administration.

Fang M, Jin Y, Bao W, Gao H, Xu M, Wang D, Wang X, Yao P, Liu L.

Int J Nanomedicine. 2012;7:5395-404. doi: 10.2147/IJN.S36257. Epub 2012 Oct 9.

2.
3.

Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.

Ji H, Tang J, Li M, Ren J, Zheng N, Wu L.

Drug Deliv. 2016;23(2):459-70. doi: 10.3109/10717544.2014.918677. Epub 2014 Jun 3.

PMID:
24892628
4.

Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.

Liu Y, Wang L, Zhao Y, He M, Zhang X, Niu M, Feng N.

Int J Pharm. 2014 Dec 10;476(1-2):169-77. doi: 10.1016/j.ijpharm.2014.09.052. Epub 2014 Oct 1.

PMID:
25280882
5.

Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.

Zhao YQ, Wang LP, Ma C, Zhao K, Liu Y, Feng NP.

Int J Nanomedicine. 2013;8:4169-81. doi: 10.2147/IJN.S50557. Epub 2013 Oct 31.

6.

Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.

Ranpise NS, Korabu SS, Ghodake VN.

Colloids Surf B Biointerfaces. 2014 Apr 1;116:81-7. doi: 10.1016/j.colsurfb.2013.12.012. Epub 2013 Dec 30.

PMID:
24445002
7.

Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin.

Li C, Zhang Y, Su T, Feng L, Long Y, Chen Z.

Int J Nanomedicine. 2012;7:5995-6002. doi: 10.2147/IJN.S38043. Epub 2012 Dec 5.

8.

Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study.

Madane RG, Mahajan HS.

Drug Deliv. 2016 May;23(4):1326-34. doi: 10.3109/10717544.2014.975382. Epub 2014 Nov 4.

PMID:
25367836
9.

Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles.

Wang W, Zhu R, Xie Q, Li A, Xiao Y, Li K, Liu H, Cui D, Chen Y, Wang S.

Int J Nanomedicine. 2012;7:3667-77. doi: 10.2147/IJN.S30428. Epub 2012 Jul 17.

10.

Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.

Meng F, Asghar S, Xu Y, Wang J, Jin X, Wang Z, Wang J, Ping Q, Zhou J, Xiao Y.

Int J Pharm. 2016 Jun 15;506(1-2):46-56. doi: 10.1016/j.ijpharm.2016.04.033. Epub 2016 Apr 16.

PMID:
27094357
11.

Nanostructured lipid carriers as a delivery system of biochanin A.

Wang Q, Cheng H, Zhou K, Wang L, Dong S, Wang D, Chen W.

Drug Deliv. 2013 Nov;20(8):331-7. doi: 10.3109/10717544.2013.838716.

PMID:
24111887
12.

Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers.

Wang F, Chen J, Dai W, He Z, Zhai D, Chen W.

Acta Pharm. 2017 Sep 1;67(3):357-371. doi: 10.1515/acph-2017-0021.

PMID:
28858837
13.

Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin.

Shangguan M, Lu Y, Qi J, Han J, Tian Z, Xie Y, Hu F, Yuan H, Wu W.

J Biomater Appl. 2014 Feb;28(6):887-96. doi: 10.1177/0885328213485141. Epub 2013 Sep 5.

PMID:
24008629
14.

[Silica-coated ethosome as a novel oral delivery system for enhanced oral bioavailability of curcumin].

Li C, Deng L, Zhang Y, Su TT, Jiang Y, Chen ZB.

Yao Xue Xue Bao. 2012 Nov;47(11):1541-7. Chinese.

PMID:
23387090
15.

Preparation, characterization and pharmacokinetic studies of linalool-loaded nanostructured lipid carriers.

Shi F, Zhao Y, Firempong CK, Xu X.

Pharm Biol. 2016 Oct;54(10):2320-8. doi: 10.3109/13880209.2016.1155630. Epub 2016 Mar 17.

PMID:
26986932
16.

A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.

Lin C, Chen F, Ye T, Zhang L, Zhang W, Liu D, Xiong W, Yang X, Pan W.

Int J Pharm. 2014 Apr 25;465(1-2):90-6. doi: 10.1016/j.ijpharm.2014.02.013. Epub 2014 Feb 12.

PMID:
24530388
17.

Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles.

Hu L, Xing Q, Meng J, Shang C.

AAPS PharmSciTech. 2010 Jun;11(2):582-7. doi: 10.1208/s12249-010-9410-3. Epub 2010 Mar 30.

18.

Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.

Khan S, Baboota S, Ali J, Narang RS, Narang JK.

Drug Dev Ind Pharm. 2016;42(2):209-20. doi: 10.3109/03639045.2015.1040414. Epub 2015 May 27.

PMID:
26016780
19.

Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats.

Kakkar V, Muppu SK, Chopra K, Kaur IP.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):339-45. doi: 10.1016/j.ejpb.2013.02.005. Epub 2013 Feb 27.

PMID:
23454202
20.

Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide.

Zhang T, Chen J, Zhang Y, Shen Q, Pan W.

Eur J Pharm Sci. 2011 Jun 14;43(3):174-9. doi: 10.1016/j.ejps.2011.04.005. Epub 2011 Apr 20.

PMID:
21530654

Supplemental Content

Support Center